Compare Newmont Corporation (NEM) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Newmont Corporation vs Sanofi SA — how do they compare? Newmont Corporation trades at $92.41 (market cap $95.23B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Newmont Corporation and Sanofi SA are close in size by market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| NEM | SNY | |
|---|---|---|
Market Cap | $95.23B | $104.83B |
Sector | Basic Materials | Health |
52-Week High | $131.95 | $52.34 |
52-Week Low | $59.86 | $41.33 |
Enterprise Value | $91.98B | $121.32B |
Dividend Yield | 1.17% | 5.5% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Newmont Corporation
Newmont Corp is primarily a gold producer with operations and/or assets in the United States, Canada, Mexico, Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. It is also engaged in the production of copper, silver, lead and zinc. The company's operations are organized in five geographic regions: North America, South America, Australia, Africa and Nevada.
Read more on NEM →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
